Celldex Therapeutics reported $-84.44M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
Agenus USD 14.4M 19.26M Dec/2025
Amgen USD 3.83B 130M Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Celldex Therapeutics USD -84.44M 2.72M Mar/2026
Glaxosmithkline GBP 2.3B 1.46B Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Northwest Biotherapeutics USD -14.32M 822K Sep/2025
Pfizer USD 4.99B 340M Mar/2026
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 9.56B 2.1B Dec/2025